Skip to main content

Ontario patients and community pharmacists are among those who stand to benefit from a government about-face on proposed changes to how drugs are bought and sold in the province.

Pharmacists had been lobbying hard to keep rebates they often receive from pharmaceutical companies in exchange for buying generic drugs, saying they needed the money to help run their stores.

The changes to the legislation, announced yesterday, will allow for "professional allowances," to be governed by a code of conduct that, among other things, limits the value to 20 per cent of the generic cost of the purchase. CP

Interact with The Globe